Attenuation of ischemic liver injury by a non-selective endothelin receptor antagonist.
Jin
M B
MB
Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pennsylvania, USA.
Zhu
Y
Y
Zhang
S
S
Ishizaki
N
N
Tanaka
H
H
Subbotin
V M
VM
Lee
R G
RG
Starzl
T E
TE
Todo
S
S
D000410:Alanine Transaminase / Q000097:blood; D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D001647:Bile Acids and Salts / Q000097:blood; D004285:Dogs; D065128:Endothelin Receptor Antagonists; D005260:Female; D006439:Hemodynamics / Q000187:drug effects*; D007511:Ischemia / Q000473:pathology; D008099:Liver / Q000098:blood supply* / Q000473:pathology / Q000503:physiopathology; D010456:Peptides, Cyclic / Q000494:pharmacology*; D015427:Reperfusion Injury / Q000517:prevention & control*
D001647:Bile Acids and Salts; D065128:Endothelin Receptor Antagonists; D010456:Peptides, Cyclic; C088196:TAK 044; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase